0.00Open0.00Pre Close0 Volume0 Open Interest3.00Strike Price0.00Turnover411.50%IV-156.41%PremiumAug 16, 2024Expiry Date1.83Intrinsic Value100Multiplier25DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.6272Delta0.3011Gamma0.59Leverage Ratio-0.0091Theta-0.0014Rho-0.37Eff Leverage0.0012Vega
Ocean Biomedical Stock Discussion
Ocean Biomedical, Inc. (Nasdaq: Ocea) Announces Patent Allowance for Malaria Antibodies That Have Potential Capability to Protect Against Infection and Treat Severe Disease
NEWS
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Allowance for Malaria Antibodies That Have Potential Capability to Protect Against Infection and Treat Severe Disease
On May 16, 2024, Ocean Biomedical (NASDAQ: OCEA) announced a new patent for malaria therapeutic antibody discoveries by Dr. Jonathan Kurtis. These antibodies aim to prevent malaria infection and treat severe cases by inducing parasite death via apoptosis during a critical stage of the malaria ...
No comment yet